Topic

Articles

The acquisition will give Genentech full rights to Jecure’s preclinical portfolio of NLRP3 inhibitors.

Genentech Acquires Jecure Therapeutics

With the $252-million acquisition of contract development, manufacturing, and testing organization Avista Pharma Solutions, Cambrex will enter the market for early stage small-molecule development and testing services.

Cambrex to Acquire Avista Pharma

Ardena has moved into its expanded headquarters, located in Gent, Belgium, as a result of continued growth.

Ardena Moves to Expanded Headquarters in Belgium

he acquisition expands the company’s formulation and analytical R&D services.

Velesco Pharma Acquires New R&D and cGMP Analytical Lab

Novartis plans to acquire Endocyte, a biopharmaceutical company, to accelerate the development of innovative radioligand technology for treating cancer.

Novartis to Acquire Endocyte in Deal Worth $2.1 Billion

Roche has acquired Tusk Therapeutics in a deal worth up to EUR 659 million (US$762 million).

Roche Acquires Tusk Therapeutics

The company’s three acquisitions over the last 12 months have increased its global presence, expanding its European footprint and bringing new localized services in Asia-Pacific and the west coast of the United States.

PCI Bolsters Global Drug Development and Commercialization Capabilities with Three Acquisitions

The divestiture of the European generic-drug business of Sanofi-Zentiva-to Advent International has been completed.

Acquisition of Sanofi’s Zentiva is Completed by Advent International

The $425-million acquisition adds formulation development and finished dosage manufacturing capabilities to Cambrex’s existing global API manufacturing network.

Cambrex Completes Acquisition of Halo Pharma

Becton Dickinson’s (BD) Advanced Bioprocessing business will be integrated into Thermo Fisher's Life Sciences Solutions segment.

Mergers and Acquisitions